December 23, 2021 | BALTIMORE –
Dear Team Members and Friends:
2021 has been an exciting year for Complete Omics – – we brought dramatic improvements to biomedical sciences and patient care by advancing our multi-omics molecular diagnostic pipelines even further. In the year of 2021, over 80 new research papers featuring Complete Omics’ technologies and platforms have been published.
Since 2021 summer, Complete Omics started to offer cutting-edge multi-omics research services backed up by our top profile publications and patents. Now we are thrilled to work with over 30 pharmaceutical corporations and over 50 research labs worldwide to implement our Complete360® multi-omics molecular diagnostic pipeline and our Valid-NEOTM companion diagnostics pipeline. Hundreds of novel biomarkers and dozens of new drug targets are identified and quantified by us, and numerous treatment approaches are being developed based on our discoveries.
We expect massive new features to be added on to our platforms over the next few years, and many exciting new discoveries ahead from ourselves and from the collaborations with scientists throughout the world.
Please follow our company’s progress or contact us at info@completeomics.com to learn more about how we can advance your research and patient care.
All of us at Complete Omics wish you a Merry Christmas and Happy New Year of 2022!
